PT-141, hormone-axis support, and the sex-hormone biomarkers that actually explain low libido.
Libido is rarely a single-cause problem. The compounds and supplements on this page address the central-nervous-system pathway (PT-141 / melanocortin), the hormone axis (testosterone, estradiol, prolactin), and the metabolic substrate that drives both. Pairing the right compound with the right biomarker panel is the difference between guessing and actually fixing it.
PT-141 (bremelanotide) is FDA-approved (Vyleesi) for premenopausal HSDD and works through melanocortin-4 receptor activation in the central nervous system — independent of vascular or hormonal pathways. Onset is fast (45 minutes), effect lasts hours. SubQ injection at 1.75–2 mg as-needed.
For men, the hormone axis is the more common root cause. Total testosterone tells half the story — free testosterone, SHBG, estradiol, and prolactin are required to interpret it. High SHBG can functionally lower free T even with normal total. High estradiol or prolactin can independently suppress libido. The hormone-support supplement stack (zinc, magnesium, vitamin D, boron, ashwagandha) addresses the substrate.
The biomarkers to track are the full sex-hormone panel plus DHEA-S and prolactin. Drawing in the morning, ideally fasted, between 7–10am gives the cleanest data.
Sign up free and we'll auto-apply the TRT / Hormone Support stack to your account. From there, log doses, upload labs, and watch your biomarkers respond — all in one dashboard.
Educational reference content only. Not medical advice. Doses cited are from published research; individual needs vary significantly. Always consult a licensed healthcare provider before starting or modifying any protocol.